Lehrstuhl für Strahlentherapie

Abstracts DEGRO 2018 Low-dose irradiation has an impact on bone metabolism as well as on local and systemic immune cell-mediated inflammation (2018) Deloch L, Rückert M, Seeling M, Nimmerjahn F, Fietkau R, Frey B, Gaipl U Conference contribution Assessment of segmentation dependence in macroscopic lung cavity extraction (2018) Khdeir A, Geimer T, Chen S, Goppert E, Dankbar M, Bert C, Maier A Conference contribution Salvage HDR/PDR brachytherapy combined with interstitial hyperthermia in locally recurrent prostate adenocarcinoma after previous irradiation - actual status of multicenter phase II study (2018) Kukielka A, Strnad V, Dabkowski M Conference contribution Pradictive Character of Immunophenotyping in peripheral Blood in Patients treated with PD-1 Immunocheckpoint Inhibitors with and without Radiotherapy (Prospective Phase IV Study ST-ICI) (2018) Hecht M, Donaubauer AJ, Harrer A, Rutzner S, Becker I, Lettmaier S, Haderlein M, et al. Conference contribution Predictors of long-term survival following radical treatment of oligometastatic NSCLC with cerebral metastases (2018) Hirschmann E, Zoske H, Weissmann T, Lettmaier S, Filimonova I, Fietkau R, Putz F Conference contribution Paragangliomas of the head and neck-local control and functional outcomes following stereotactic radiotherapy (2018) Weissmann T, Semrau S, Fietkau R, Putz F Conference contribution LOW DOSE RADIATION HAS A POSITIVE IMPACT ON BONE METABOLISM IN AN EXPERIMENTAL MODEL OF INFLAMMATORY ARTHRITIS (2018) Deloch L, Rückert M, Hueber A, Herrmann M, Fietkau R, Frey B, Gaipl U Conference contribution QOL After APBI (Multicatheter Brachytherapy) Versus WBI: 5-Year Results, Phase 3 GEC-ESTRO Trial (2018) Schaefer R, Strnad V, Polgar C, Uter W, Hildebrandt G, Ott OJ, Kauer-Dorner D, et al. Conference contribution Multicenter quality assurance evaluation of MR-guided deep hyperthermia systems (2018) Curto S, Mulder T, Aklan B, Mils O, Schmidt M, Lamprecht U, Peller M, et al. Conference contribution NAR score as surrogate for disease-free survival in the CAO/ARO/AIO-04 phase 3 rectal cancer trial (2018) Fokas E, Fietkau R, Hartmann A, Hohenberger W, Grützmann R, Ghadimi M, Liersch T, et al. Conference contribution